Calcium Channels May Be Therapeutic Target in Parkinson’s, Stem Cell Study Suggests

Targeting specific calcium channels in dopamine-producing neurons may be a therapeutic target for Parkinson’s disease, according to research involving cells derived from Parkinson’s patients. The study, “T-type calcium channels determine the vulnerability of dopaminergic neurons to mitochondrial stress in familial Parkinson’s disease,” was published in Stem Cell…

Cavion’s New CMO to Lead Cav3 Platform Development for Neurological Diseases

The biopharmaceutical company Cavion announced the appointment of a new executive vice president of research and development and chief medical officer to lead efforts advancing therapies based on the company’s T-type calcium channel (Cav3) platform targeting neurological diseases such as Parkinson’s disease (PD). Spyridon “Spyros” Papapetropoulos, MD, PhD, has been named the…